| Dr Phillip D Hylton, MD | |
|
3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66103-2937 | |
| (913) 588-6122 | |
| (913) 588-7570 |
| Full Name | Dr Phillip D Hylton |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487699112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 118208 (Missouri) | Secondary |
| 207T00000X | Neurological Surgery | 04-28102 (Kansas) | Primary |
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922144856 PECOS PAC ID: 8921911587 Enrollment ID: O20101228000020 |
News Archive
CQ HealthBeat: "Education or propaganda? Or 'beyond propaganda?' The Centers for Medicare and Medicaid Services announced Monday that it will soon send Medicare beneficiaries a special mailing on 'the immediate benefits they may see' from the health care overhaul law. Getting accurate information about key provisions of the law will help Medicare enrollees 'to be on the alert for any scams asking for personal information,' explained acting CMS Administrator Marilyn Tavenner in an agency news release Monday.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that it has successfully completed Phase I development of its rapid virus detection system, a non-invasive, point-of-care test to test patient samples and identify various forms of influenza within minutes. Phase II of the development, which the Company expects to complete by the end of 2010, is planned to launch in February 2010.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.
Status epilepticus (SE) is a true medical and neurologic emergency. To better understand the causes, treatment approaches and associated outcomes among SE patients, investigators at the Veterans Affairs Greater Los Angeles Healthcare System retrospectively reviewed all SE cases treated within their system over an eight year period.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Phillip D Hylton, MD 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66103-2937 Ph: (913) 588-6122 | Dr Phillip D Hylton, MD 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66103-2937 Ph: (913) 588-6122 |
News Archive
CQ HealthBeat: "Education or propaganda? Or 'beyond propaganda?' The Centers for Medicare and Medicaid Services announced Monday that it will soon send Medicare beneficiaries a special mailing on 'the immediate benefits they may see' from the health care overhaul law. Getting accurate information about key provisions of the law will help Medicare enrollees 'to be on the alert for any scams asking for personal information,' explained acting CMS Administrator Marilyn Tavenner in an agency news release Monday.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that it has successfully completed Phase I development of its rapid virus detection system, a non-invasive, point-of-care test to test patient samples and identify various forms of influenza within minutes. Phase II of the development, which the Company expects to complete by the end of 2010, is planned to launch in February 2010.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.
Status epilepticus (SE) is a true medical and neurologic emergency. To better understand the causes, treatment approaches and associated outcomes among SE patients, investigators at the Veterans Affairs Greater Los Angeles Healthcare System retrospectively reviewed all SE cases treated within their system over an eight year period.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
› Verified 5 days ago
Anne F Stanton, ARNP Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Dept. Of Neurosurgery, Mail Stop 3021, Kansas City, KS 66160 Phone: 913-588-6180 Fax: 913-588-7570 | |
Dr. Joseph Domino, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 | |
Bailey Raine Yekzaman, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 3021, Kansas City, KS 66160 Phone: 913-588-1227 | |
Dr. Jean-luc Kalonda Kabangu, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Dr. Sarah Isobel Woodrow, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-6125 Fax: 913-588-7570 | |
Jules M Nazzaro, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 3021, Kansas City, KS 66160 Phone: 913-588-5129 Fax: 913-588-5337 | |
Jeremy Charles Peterson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Hospital School Of, Dept. Of Neurosurgery, 3901 Rainbow Blvd., Ms 3021, Kansas City, KS 66160 Phone: 913-588-6119 Fax: 913-588-7570 |